Drugs in pregnancy--the issues for 2010

Area of Science:

• Pharmacology and Therapeutics
• Maternal-Fetal Medicine
• Drug Safety

Background:

• Evaluating medication safety during pregnancy is critical.
• Existing data collection and surveillance methods were insufficient.
• Benchmarks for drug evaluation in pregnancy were needed.

Purpose of the Study:

• To establish benchmarks for evaluating medications during pregnancy.
• To address the need for improved fetal safety data collection and analysis.
• To create a framework for ongoing post-marketing surveillance of medications used by pregnant individuals.

Main Methods:

• Convened a symposium on medication evaluation in pregnancy.
• Facilitated consensus on data collection and analysis needs.
• Established CaseMed-Pregnancy (Canadian Alliance for Safe and Effective Medication During Pregnancy and Breastfeeding).

Main Results:

• Consensus reached on the necessity of data collection and analysis for fetal safety.
• Agreement on the importance of ongoing post-marketing surveillance.
• Establishment of a national alliance dedicated to medication safety in pregnancy and breastfeeding.

Conclusions:

• Benchmarks for evaluating medications in pregnancy are essential.
• Robust data collection and post-marketing surveillance are crucial for ensuring fetal safety.
• CaseMed-Pregnancy provides a vital platform for advancing safe medication practices for pregnant and breastfeeding individuals.